This special Monday Lunch Live will feature a replay of a previous Ovarian Cancer Awareness Month special.
While most women experience symptoms before diagnosis, ovarian cancer is often not detected until an advanced stage, when the prognosis is poorer.
The five-year survival rate for women diagnosed at Stage I is about 90 per cent, but for Stage III it is around 40 per cent.
Many people with ovarian cancer, or who have a relative with ovarian cancer, seek information about whether there is an inherited cause.
This Monday Lunch Live event featured a panel discussion exploring the link between ovarian cancer and genetics. The discussion was facilitated by A/Prof Sumitra Ananda and Dr Niveditha Rajadevan with A/Prof Orla McNally, A/Prof Yoland Antill and Sonja Pilon as panellists.
Associate Professor Sumitra Ananda
Medical Oncologist/Clinical Research Fellow
Peter MacCallum Cancer Centre
The Royal Melbourne Hospital
Walter and Eliza Hall Institute of Medical Research
Dr Niveditha Rajadevan
Gynae Oncologist
The Royal Women's Hospital
Associate Professor Orla McNally
Director of the Oncology and Dysplasia Service
The Royal Women's Hospital
Associate Professor Yoland Antill
Medical Oncologist/Cancer Genetics specialist
Cabrini, Peninsula and Melbourne Health Services
Christine Crupi
Consumer
